My takeaway from the PR is this, and it is no smal
Post# of 154612

Quote:
The Company confirmed that 5/5 patients (100%) who demonstrated a significant increase in PD-L1 expression after receiving leronlimab and received treatment with any ICI remain alive today. Four of these patients (80%) currently identify as having no evidence of disease, and the fifth patient is alive and identified by the clinical site as “stable.”
EVERY patient who had a significant increase in PD-L1 expression after receiving Leron is alive today.
This means we should be able to cure hundreds of thousands of people with TNBC every year.

